Glucocorticoid receptor-binding characteristics in severe asthma

Area of Science:

• Immunology
• Pulmonology
• Pharmacology

Background:

• Severe asthma pathogenesis remains unclear.
• Understanding glucocorticoid-receptor (GR) function is crucial for severe asthma management.
• Oral glucocorticoids are often required for severe asthma but their efficacy can be variable.

Purpose of the Study:

• To investigate potential alterations in glucocorticoid-receptor (GR) binding characteristics in severe asthma.
• To assess the functional capacity of GRs in patients requiring continuous oral glucocorticoid therapy.
• To determine if GR abnormalities correlate with the need for long-term oral glucocorticoid treatment.

Main Methods:

• Assessed GR-binding affinity (Kd) and receptor number (n) in peripheral blood monocytes (PBM) from normal subjects, untreated asthmatics, and severe asthmatics.
• Utilized a 3H dexamethasone ligand-binding assay and Scatchard analysis for GR characterization.
• Measured dexamethasone's in vitro inhibition of RANTES release from PBM using ELISA.

Main Results:

• No significant differences in GR-binding affinity (Kd) or receptor number (n) were observed between the three patient groups.
• Dexamethasone effectively inhibited RANTES release in vitro across all groups, with similar concentration-response curves.
• Severe asthmatics on long-term oral glucocorticoids exhibited normal GR-binding characteristics and functional receptor activity.

Conclusions:

• Severe asthma does not appear to be associated with abnormalities in glucocorticoid receptor-binding characteristics.
• Glucocorticoid receptors remain functional in patients with severe asthma, even after prolonged oral glucocorticoid therapy.
• These findings suggest that GR resistance is unlikely to be the primary mechanism limiting glucocorticoid efficacy in severe asthma.